Want to contact a Washington, DC Mavik lawyer? ...Get a free case evaluation from one of our Washington, DC Mavik lawyers now.

Mavik - News Articles

News - Orlistat Most Effective Antiobesity Drug for Reducing Blood Pressure and Cholesterol Levels: Presented at ECO
May 22, 2008
DG News -
By Timothy A. O'Leary GENEVA -- May 22, 2008 -- The antiobesity drug orlistat reduces blood pressure, total cholesterol, and low-density lipoprotein (LDL) cholesterol more effectively than rimonabant, sibutramine, or placebo, according to research presented here at the 16th European Congress on ...
News - Antiobesity, Antihypertensive Drug Combination Reduces Weight and Blood Pressure: Presented at ECO
May 22, 2008
DG News -
By Timothy A. O'Leary GENEVA -- May 22, 2008 -- Patients with obesity and hypertension can achieve significant reductions in weight and blood pressure with a low-fat, low-calorie diet and a regime of the antiobesity drug sibutramine and the antihypertension combination verapamil-trandolapril, according to ...
News Centre@myiris.com India's Most Comprehensive Financial Destination
Jun 14, 2007
Myiris.com, India -
Lupin received US FDA`s final approval for the company`s abbreviated new drug application for Trandolapril tablets, 1mg, 2mg and 4mg. The company further informed that it has commenced the commercial shipments of the product.The company`s Trandolapril tablets are the ...
Lupin's Trandolapril gets USFDA nod
Jun 14, 2007
Business Standard, India -
Lupin, a pharmaceutical company, has recieved the required approval from the US Food and Drug Administration (USFDA) for multiple strengths of Trandolapril tablets used in the treatment of hypertension.Kamal Sharma, managing director, Lupin, said, "We are delighted with the timely approval ...
Prescription Drugs > FDA Approves Trandolapril Tablets
Jun 14, 2007
eMaxHealth.com, NC -
US Food and Drug Administration has granted final approval for Lupin Pharmaceuticals's Abbreviated New Drug Application for Trandolapril Tablets, 1mg, 2mg and 4mg. Commercial shipments of Trandolapril tablets have commenced.Lupin's Trandolapril Tablets are the AB-rated generic equivalent of Abbott's ...
Aurobindo Pharma gets USFDA approval for Trandolapril tablets
Jun 15, 2007
Myiris.com, India -
Trandolapril is the Generic equivalent of Abbott`s Mavik tablets, indicated for the treatment of hypertension. This is the fourth anti hypertensive (medicines regulating blood pressure) of the company bagging USFDA`s nod.  Trandolopril is also employed in combination with diuretics or ...
India's Aurobindo Pharma gets FDA approval for Trandolapril tablets - Forbes.com
Jun 15, 2007
Forbes, NY -
Trandolapril has a current market share of 50 mln usd, the company said in a statement to the Bombay Stock Exchange. Aurobindo said the approvals are for tablets in 1, 2 and 4 mg strengths. TFN.newsdesk@thomson.comrku/man/gpCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or ...
Indian shares open higher on firm Asian markets; Sensex up 1.04 pct UPDATE | Latest News | News | Hemscott
Jun 13, 2007
Hemscott, UK -
up 1.36 pct after the pharma company said it has got US Food and Drug Administration's approval for generic version of Abbott's hypertension drug Mavik. ...
The Hindu News Update Service
Jun 14, 2007
Hindu, India -
This abbreviated new drug application (ANDA) - Trandolapril tablets, are the AB-rated generic equivalent of Abbott's Mavik tablets that are indicated for the treatment of hypertension. According to IMS sales data, the Trandolapril tablets had annual sales of about 49 million ...
www.equitybulls.com - Your One Stop Shop for Financial Services !!!
Jun 15, 2007
Equity Bulls, India -
Trandolapril is the Generic equivalent of Abbott's Mavik® Tablets, indicated for the treatment of hypertension. This is the fourth Anti hypertensive (Medicines regulating blood pressure) of the Company bagging USFDA's nod. Trandolopril is an ACE inhibitor, and amongst the class, ...
Lupin Receives Final FDA Approval for Trandolapril
Jun 15, 2007
FDA news (subscription), VA -
Trandolapril is the generic equivalent of Abbott’s Mavik, indicated for the treatment of hypertension. The brand product had annual sales of approximately $49 million for the 12 months ending in December 2006, according to the company.Register NowPrint This PageEmail This ...
Lupin announces FDA approval of Trandolapril tablets
Jun 18, 2007
News-Medical.net, Australia -
Lupin's Trandolapril Tablets are the AB-rated generic equivalent of Abbott's Mavik(R) Tablets, indicated for the treatment of hypertension. The brand product had annual sales of approximately $49 million for the twelve months ended December 2006, based on ...
Lupin gets FDA approval for generic version of Abbott's hypertension drug Mavik - Forbes.com
Jun 13, 2007
Forbes, NY -
Mavik had annual sales of about 49 mln usd for the year ended December 2006, based on IMS sales data, the pharmaceutical company said. ...
Impaired glycemic control reversible when switching off diuretic-based therapy
May 25, 2007
TheHeart.Org, NY -
The hypothesis-generating study, an extension of the Study of Trandolapril/Verapamil SR And Insulin Resistance (STAR), was presented earlier this week at ...
Alzheimer's Risk Shielded by BP Drugs - The Money Times
May 7, 2007
The Money Times, India -
The ACE inhibitor class includes drugs like captropril, fosinopril, lisinopril, perindopril, ramipril and trandolapril. Kaycee, after rigorous experimentation, held that people who take this class of drugs, have a 50% lesser chance of mental ...
ACE Inhibitors May Reduce Alzheimer's Risk | DogFlu.ca
May 7, 2007
Dog Flu Diet and Diseases, Canada -
Certain drugs used to treat people who have high blood pressure may also reduce the risk of Alzheimer's disease. The drugs in question belong to a class of drugs known as ACE inhibitors, which are drugs used to reach the brain, and according to the researchers from ...
News - Some Hypertension Drugs May Help Reduce Dementia Risk
May 7, 2007
DG News -
WINSTON SALEM, NC -- May 7, 2007 -- Some high blood pressure medicines may help protect older adults from declines in memory and other cognitive function, according to new research from Wake Forest University School of Medicine, reported Saturday at the annual meeting of the ...
Alzheimer’s Disease - Lisinopril and Certain ACE Inhibitors Lower Risk – Not All ACE Drugs Reduce Dementia Some Increase Chances | Best Syndication
May 7, 2007
Best Syndication, CA -
(Best Syndication) Researchers from Wake Forest University School of Medicine say that some ACE (angiotensin-converting enzyme) inhibitors can slow the decline in memory and other cognitive functions. They say that these drugs reduce the inflammation that might contribute ...
Centrally active ACE inhibitors linked to lower rates of mental decline in the elderly
May 7, 2007
TheHeart.Org, NY -
Seattle, WA - Compared with other antihypertensive agents, centrally active ACE inhibitors are associated with slower rates of cognitive decline over six ...
AGS: Centrally Active ACE Inhibitors May Slow Cognitive Decline - CME Teaching Brief® - MedPage Today
May 7, 2007
MedPage Today, NJ -
By Peggy Peck, Managing Editor, MedPage Today. SEATTLE, May 7 -- Treating hypertension with centrally active angiotensen enzyme inhibitors may have the added benefit of reducing the risk of cognitive decline, researchers here reported. ...
Want to contact a Washington, DC Mavik lawyer? ...Get a free case evaluation from one of our Washington, DC Mavik lawyers now.

Pages:   1   2   3   Next

AddThis Social Bookmark Button

 

Need A Mavik Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Mavik Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Mavik Case - Submit Your Information Below

Do you need legal assistance with your Mavik case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Mavik Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.